| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.96B | +24.6% |
| Cost of Revenue | $410.1M | +31.6% |
| R&D Expense | $1.34B | +9.4% |
| SG&A Expense | $821.0M | +14.6% |
| Operating Income | -$613.0M | +10.1% |
| Pre-tax Income | -$602.3M | +10.9% |
| Income Tax | $8.0M | +747.7% |
| Net Income | -$610.3M | +9.5% |
| EPS (Basic) | -$3.30 | +10.8% |
| EPS (Diluted) | -$3.30 | +10.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $319.9M | -24.7% |
| Accounts Receivable | $501.9M | +28.9% |
| Inventory | $427.2M | +112.9% |
| Current Assets | $2.80B | -2.3% |
| Total Assets | $3.67B | -1.2% |
| Current Liabilities | $818.4M | +43.9% |
| Stockholders' Equity | $2.80B | -8.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$453.8M | +9.1% |
| Capital Expenditures | $77.3M | +47.8% |
| Investing Cash Flow | $228.2M | -21.0% |
| Financing Cash Flow | $125.4M | +61.2% |
| Free Cash Flow | -$531.1M | +3.7% |